FDA approves Betaconnect electronic autoinjector for multiple sclerosis- Bayer HealthCare
The FDA has approved Betaconnect, from Bayer HealthCare, an electronic autoinjector in the treatment of relapsing-remitting multiple sclerosis (RRMS). Betaconnect will be available exclusively to Betaseron (interferon beta-1b) patients beginning in early 2016.
The new autoinjector offers customizable injection speed and depth settings that allow patients to inject quietly with precision at the touch of a button. Additionally, the automatic needle insertion and retraction with a visual and audio end-of-dose indication lets patients know when the injection is complete.
160 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.